Solventum Corporation SOLV
89.50
0.91
1.03%
as of 25 Sep
- Market cap
- $15.1B
- P/E
- 10.9×
Follow SOLV
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Solventum Corporation (SOLV) Operating margin
Solventum Corporation's operating margin over the twelve months to 30 June 2026 was 25.0%, down 1.2 percentage points from fiscal 2025 (26.2%). That is above the Medical Instruments & Supplies industry median of 1.64% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Annual
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 26.2% | 13.65 |
| FY2024 | 12.6% | (8.09) |
| FY2023 | 20.6% | (0.18) |
| FY2022 | 20.8% | — |
Quarterly
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 8.19% | 4.20 |
| Mar 2026 | 3.99% | (2.27) |
| Dec 2025 | 6.26% | (74.37) |
| Sep 2025 | 80.6% | 70.73 |
| 10 more quarters | Free account |
Operating margin against peers
| Company | Operating margin |
|---|---|
| SOLV Solventum Corporation | 25.0% |
| WST West Pharmaceutical Services, Inc. compare | 20.5% |
| ALGN Align Technology, Inc. compare | 13.2% |
| COO The Cooper Companies, Inc. compare | 12.8% |
| ATR AptarGroup, Inc. compare | 12.1% |
| ALC Alcon compare | 8.73% |
| RGEN Repligen Corporation compare | 8.23% |
| BAX Baxter International Inc. compare | −2.39% |
| AVTR Avantor, Inc. compare | −4.59% |
| Medical Instruments & Supplies industry median | 1.64% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on SOLV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement